Patients with CF tend to have fatigue and dyspnoea due to chronic pulmonary infections, so reducing the amount of energy spent during activities can help patients feel better and gain more independence. At best, current treatments delay the decline in organ function. Because of the wide variation in disease symptoms, treatment typically occurs at specialist multidisciplinary centers and is tailored to the individual. Targets for therapy are the lungs, gastrointestinal tract (including pancreatic enzyme supplements), the reproductive organs (including assisted reproductive technology), and psychological support.The most consistent aspect of therapy in CF is limiting and treating the lung damage caused by thick mucus and infection, with the goal of maintaining quality of life. Intravenous, inhaled, and oral antibiotics are used to treat chronic and acute infections. Mechanical devices and inhalation medications are used to alter and clear the thickened mucus. These therapies, while effective, can be extremely time-consuming. Oxygen therapy at home is recommended in those with significant low oxygen levels. Many people with CF use probiotics, which are thought to be able to correct intestinal dysbiosis and inflammation, but the clinical trial evidence regarding the effectiveness of probiotics for reducing pulmonary exacerbations in people with CF is uncertain. Antibiotics
Many people with CF are on one or more antibiotics at all times, even when healthy, to prophylactically suppress infection. Antibiotics are absolutely necessary whenever pneumonia is suspected or a noticeable decline in lung function is seen, and are usually chosen based on the results of a sputum analysis and the persons past response.
Tinea imbricata (also known in parts of Indonesia as “Kaskado”) is a superficial fungal infection of the skin limited to southwest Polynesia, Melanesia, Southeast Asia, India, and Central America. : 303  The skin lesions are often itchy, and mainly in the torso and limbs. The name is derived from the Latin for "tiled" (imbricata) since the lesions are often lamellar. It is often treated with griseofulvin or terbinafine.The risk of developing tinea imbricata is probably inherited as an autosomal recessive trait.Tinea imbricata is associated with Trichophyton concentricum. Tinea pseudoimbricata
The term "tinea pseudoimbricata" synonymous with "tinea indecisiva", was coined to describe a form of tinea mimicking the concentric rings of tinea imbricata, but is caused by local or systemic immunosuppression. Since then, 3 cases of Trichophyton tonsurans have been associated with it, as well as Trichophyton rubrum which can trigger mycosis fungoides. Mixed infections with scabies have been described to produce tinea pseudoimbricata.As of 2015 in India, corticosteroid–antifungal–antibacterial combinations sold as over-the-counter drug have led to an increase in chronic, recurrent, difficult to treat fungal infections of the skin, including tinea pseudoimbricata. See also
Skin lesion
List of cutaneous conditions

References


== External links ==